Tau protein: Relevance to Parkinson's disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Arima, 1999, Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies, Brain Research, 843, 53, 10.1016/S0006-8993(99)01848-X
Bancher, 1993, Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients, Neuroscience Letters, 162, 179, 10.1016/0304-3940(93)90590-H
Biernat, 1993, Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding, Neuron, 11, 153, 10.1016/0896-6273(93)90279-Z
Cookson, 2005, The biochemistry of Parkinson's disease, Annual Review of Biochemistry, 74, 29, 10.1146/annurev.biochem.74.082803.133400
De Vos, 2008, Role of axonal transport in neurodegenerative diseases, Annual Review of Neuroscience, 31, 151, 10.1146/annurev.neuro.31.061307.090711
Dixit, 2008, Differential regulation of dynein and kinesin motor proteins by tau, Science, 319, 1086, 10.1126/science.1152993
Drubin, 1986, Tau protein function in living cells, Journal of Cell Biology, 103, 2739, 10.1083/jcb.103.6.2739
Duka, 2009, Alpha-synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models, The FASEB Journal, 23, 2820, 10.1096/fj.08-120410
Edwards, 2010, Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease, Annals of Human Genetics, 74, 97, 10.1111/j.1469-1809.2009.00560.x
Frasier, 2005, Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein, Experimental Neurology, 192, 274, 10.1016/j.expneurol.2004.07.016
Giasson, 2003, Initiation and synergistic fibrillization of tau and alpha-synuclein, Science, 300, 636, 10.1126/science.1082324
Hanger, 2009, Tau phosphorylation: the therapeutic challenge for neurodegenerative disease, Trends in Molecular Medicine, 15, 112, 10.1016/j.molmed.2009.01.003
Harada, 1994, Altered microtubule organization in small-calibre axons of mice lacking tau protein, Nature, 369, 488, 10.1038/369488a0
Ishizawa, 2003, Colocalization of tau and alpha-synuclein epitopes in Lewy bodies, Journal of Neuropathology & Experimental Neurology, 62, 389, 10.1093/jnen/62.4.389
Ittner, 2008, Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia, Proceedings of the National Academy of Sciences of the United States of America, 105, 15997, 10.1073/pnas.0808084105
Jensen, 1999, Alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356, The Journal of Biological Chemistry, 274, 25481, 10.1074/jbc.274.36.25481
Joachim, 1987, Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders, Annals of Neurology, 22, 514, 10.1002/ana.410220411
Kotzbauer, 2004, Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation, Experimental Neurology, 187, 279, 10.1016/j.expneurol.2004.01.007
Lee, 2001, Neurodegenerative tauopathies, Annual Review of Neuroscience, 24, 1121, 10.1146/annurev.neuro.24.1.1121
Lewy, 1913, Zur pathologischen Anatomie der Paralysis agitans, Deutsche Zeitschrift für Nervenheilkunde, 50, 50
Maccioni, 1995, Role of microtubule-associated proteins in the control of microtubule assembly, Physiological Reviews, 75, 835, 10.1152/physrev.1995.75.4.835
Morfini, 2007, 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C, Proceedings of the National Academy of Sciences of the United States of America, 104, 2442, 10.1073/pnas.0611231104
Muntane, 2008, Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies, Neuroscience, 152, 913, 10.1016/j.neuroscience.2008.01.030
Saha, 2004, Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons, Journal of Cell Science, 117, 1017, 10.1242/jcs.00967
Schneider, 2006, Substantia nigra tangles are related to gait impairment in older persons, Annals of Neurology, 59, 166, 10.1002/ana.20723
Shaw-Smith, 2006, Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability, Nature Genetics, 38, 1032, 10.1038/ng1858
Simon-Sanchez, 2009, Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nature Genetics, 41, 1308, 10.1038/ng.487
Skipper, 2004, Linkage disequilibrium and association of MAPT H1 in Parkinson disease, American Journal of Human Genetics, 75, 669, 10.1086/424492
Spires-Jones, 2009, Tau pathophysiology in neurodegeneration: a tangled issue, Trends in Neurosciences, 32, 150, 10.1016/j.tins.2008.11.007